Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics
- PMID: 22354002
- PMCID: PMC3369675
- DOI: 10.1182/blood-2011-11-387324
Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics
Abstract
Monoclonal gammopathy of undetermined significance (MGUS), a precursor to multiple myeloma (MM), is one of the most common premalignant conditions in the general population. The cause of MGUS is largely unknown. Recent studies show that there is an increased prevalence of MGUS in blood relatives of persons with lymphoproliferative and plasma cell proliferative disorders, suggesting presence of shared underlying genetic influences. In the past few years, additional studies have examined risk factors and biologic characteristics that may contribute to the increased prevalence of MGUS among relatives of probands with MGUS, MM, and other blood malignancies. This article reviews the known epidemiology and risk factors for familial MGUS and myeloma, the risk of lymphoproliferative disorders and other malignancies among blood-relatives of patients with MGUS and MM, and discusses future directions for research.
Similar articles
-
[Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].Przegl Lek. 2012;69(5):194-6. Przegl Lek. 2012. PMID: 23050415 Review. Polish.
-
Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.Br J Haematol. 2012 May;157(4):472-5. doi: 10.1111/j.1365-2141.2012.09075.x. Br J Haematol. 2012. PMID: 22629552 Free PMC article.
-
Differences in the distribution of cytogenetic subtypes between multiple myeloma patients with and without a family history of monoclonal gammopathy and multiple myeloma.Eur J Haematol. 2013 Sep;91(3):193-195. doi: 10.1111/ejh.12133. Epub 2013 Jul 22. Eur J Haematol. 2013. PMID: 23647020 Free PMC article.
-
Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects.Curr Hematol Malig Rep. 2020 Apr;15(2):45-55. doi: 10.1007/s11899-020-00569-2. Curr Hematol Malig Rep. 2020. PMID: 32222885 Review.
-
Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.Am J Nephrol. 2012;35(4):365-71. doi: 10.1159/000337482. Epub 2012 Apr 2. Am J Nephrol. 2012. PMID: 22473253
Cited by
-
Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor.J Clin Invest. 2015 Jan;125(1):316-23. doi: 10.1172/JCI76802. Epub 2014 Dec 8. J Clin Invest. 2015. PMID: 25485683 Free PMC article.
-
Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis.Onco Targets Ther. 2016 Jul 1;9:4015-22. doi: 10.2147/OTT.S102733. eCollection 2016. Onco Targets Ther. 2016. PMID: 27445492 Free PMC article.
-
Influence of structural racism on cancer health disparities: Tailoring measures relevant to multiple myeloma.Cancer. 2024 Dec 1;130(23):4012-4019. doi: 10.1002/cncr.35512. Epub 2024 Aug 11. Cancer. 2024. PMID: 39127894 Free PMC article.
-
Clinicopathological significance of the p16 hypermethylation in multiple myeloma, a systematic review and meta-analysis.Oncotarget. 2017 Jun 27;8(47):83270-83279. doi: 10.18632/oncotarget.18742. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137341 Free PMC article.
-
Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium.Br J Haematol. 2016 Oct;175(1):87-101. doi: 10.1111/bjh.14199. Epub 2016 Jun 22. Br J Haematol. 2016. PMID: 27330041 Free PMC article.
References
-
- Criteria for the classification of monoclonal gammopathies, multiple myeloma, and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121(5):749–757. - PubMed
-
- Kyle R, Therneau T, Rajkumar S, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354(13):1362–1639. - PubMed
-
- Iwanaga M, Tagawa M, Tsukasaki K, Kamihira S, Tomonaga M. Prevalence of monoclonal gammopathy of undetermined significance: study of 52802 persons in Nagasaki City, Japan. Mayo Clin Proc. 2007;82(12):1474–1479. - PubMed
-
- Landgren O, Katzmann J, Hsing A, et al. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc. 2007;82(12):1468–1473. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous